A Multifunctional Wearable Device with a Graphene/Silver Nanowire Nanocomposite for Highly Sensitive Strain Sensing and Drug Delivery

Ge Shi, Tianqing Liu, Zlatko Kopecki, Allison J. Cowin, Ivan Lee, Jing‐Hong Pai, Sean E. Lowe, Yu Lin ZhongC 2019 · DOI

TL;DR

This paper presents a novel, low-cost wearable device that combines highly sensitive strain sensing with transdermal drug delivery. The device utilizes a graphene/silver nanowire composite on a dry adhesive substrate, enabling it to monitor human motion and physiological signals while simultaneously delivering therapeutic nanoparticles through the skin.

What Problem Does This Paper Address?

The development of wearable electronic devices for health monitoring, human-machine interaction, and therapy is a rapidly growing field. However, existing skin-mountable strain sensors often suffer from limited stretchability, poor adhesion to the skin, and a lack of multifunctionality. Furthermore, transdermal drug delivery systems often require separate devices or have limitations in their ability to deliver drugs effectively and painlessly. This paper addresses the need for a single, integrated, and highly effective wearable device that can perform both sensitive strain sensing and targeted drug delivery, overcoming the limitations of current technologies.

Methods

The researchers developed a multifunctional wearable device by integrating three key components:

  • Dry Adhesive Substrate: A polydimethylsiloxane (PDMS) film with a micropillar array was fabricated using a simple photolithography technique. This design mimics the hierarchical structures found in gecko feet, providing a large contact area and strong adhesion to the skin, comparable to medical tape but with improved reusability and breathability.
  • Strain Sensing Component: A highly sensitive strain sensor was created by layering graphene nanoplatelets (GnPs) and silver nanowires (AgNWs) onto the PDMS substrate using a vacuum filtration method. This composite leverages the high piezoresistivity of GnPs and the conductivity and stretchability of AgNWs to create a robust sensing element. The optimal AgNW to GnP ratio was determined to balance linearity and sensitivity.
  • Transdermal Drug Delivery System: Polylactic-co-glycolic acid (PLGA) nanoparticles, loaded with a model drug (deferoxamine) and fluorescently tagged, were dispersed within a chitosan hydrogel. This hydrogel was then coated onto the strain sensor. The chitosan hydrogel acts as a matrix that facilitates the release of nanoparticles into the skin.

The fabrication process involved several steps, including SU-8 template creation, PDMS micropillar molding, layer-by-layer deposition of GnPs and AgNWs, and integration of the drug delivery system. Characterization techniques included SEM, TEM, Raman spectroscopy, and electrochemical measurements.

Datasets

Not discussed in the paper. The study focuses on the fabrication and characterization of a novel device and its performance in vitro and ex vivo.

Key Insights and Ideas

  • Synergistic Sensing: Combining GnPs and AgNWs creates a strain sensor that benefits from the high piezoresistivity of GnPs and the excellent conductivity and stretchability of AgNWs, leading to both high sensitivity and durability.
  • Bio-inspired Adhesion: The micropillar array on the PDMS substrate provides a highly effective and conformal dry adhesive interface with the skin, overcoming the limitations of traditional tapes.
  • Integrated Theranostics: The seamless integration of strain sensing and drug delivery into a single wearable device opens new possibilities for "theranostic" applications, where health monitoring and treatment can occur simultaneously.
  • Controlled Nanoparticle Delivery: The chitosan hydrogel effectively delivers PLGA nanoparticles to the stratum corneum, achieving a penetration depth of approximately 60 µm, demonstrating the potential for targeted drug delivery.

Key Results

  • Strain Sensing: The sensor demonstrated high piezoresistivity with a gauge factor of 41.5 (at an AgNW/GnP ratio of 1:6), capable of detecting subtle human motions like finger bending and radial/ulnar artery pulses. It showed remarkable stability and reproducibility over 1000 stretching cycles.
  • Adhesion: The dry adhesive substrate exhibited a pull-off strength of ~1.0 N/cm², allowing it to adhere to skin for over 5 hours.
  • Drug Delivery: In vitro studies using a skin model showed that PLGA nanoparticles penetrated the epidermis, reaching a depth of ~31.90 µm after 12 hours. Ex vivo studies on porcine skin confirmed penetration up to the stratum spinosum and stratum basale, with a maximum observed depth of 60 µm.
  • Response Time: The sensor's response time was measured to be less than 50 ms, comparable to the response time of human skin to external stimuli.

Limitations and Future Work

The authors acknowledge two main limitations:

  • Dust Accumulation: The dry adhesive substrate, while effective, can accumulate dust over time, potentially reducing its pull-off strength.
  • Drug Payload Size: The current transdermal drug delivery system is limited to carrying low-molecular-weight drugs within the PLGA nanoparticles.

Future work suggested includes:

  • Enhanced Adhesion: Investigating more advanced techniques to fabricate bio-inspired adhesives for improved long-term adhesion and resistance to dust.
  • Strain Effects on Drug Delivery: Further research into how mechanical strain on the sensor might influence the drug release process.
  • Broader Applications: Exploring the delivery of a wider range of drugs and addressing dermatological conditions with impaired skin barriers.

Summary updated

Abstract

Advances in wearable, highly sensitive and multifunctional strain sensors open up new opportunities for the development of wearable human interface devices for various applications such as health monitoring, smart robotics and wearable therapy. Herein, we present a simple and cost-effective method to fabricate a multifunctional strain sensor consisting of a skin-mountable dry adhesive substrate, a robust sensing component and a transdermal drug delivery system. The sensor has high piezoresisitivity to monitor real-time signals from finger bending to ulnar pulse. A transdermal drug delivery system consisting of polylactic-co-glycolic acid nanoparticles and a chitosan matrix is integrated into the sensor and is able to release the nanoparticles into the stratum corneum at a depth of ~60 µm. Our approach to the design of multifunctional strain sensors will lead to the development of cost-effective and well-integrated multifunctional wearable devices.
BibTeX
@inproceedings{shi2019multifunctional,
  author = {Ge Shi and Tianqing Liu and Zlatko Kopecki and Allison J. Cowin and Ivan Lee and Jing‐Hong Pai and Sean E. Lowe and Yu Lin Zhong},
  title = {{A Multifunctional Wearable Device with a Graphene/Silver Nanowire Nanocomposite for Highly Sensitive Strain Sensing and Drug Delivery}},
  booktitle = {C},
  year = {2019},
  doi = {10.3390/c5020017},
}
Figure